Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Azienda Ospedaliera Universitaria Integrata Verona
Sponsor

Azienda Ospedaliera Universitaria Integrata Verona

Italy Piazzale Ludovico Antonio Scuro 10, 37134 Verona, Italy

About the sponsor

The sponsor supports clinical research in multiple sclerosis across relapsing and progressive forms, with attention to inflammatory activity, imaging markers, and chronic disease burden.

  • Secondary progressive multiple sclerosis
  • Relapsing-remitting multiple sclerosis
  • Active progressive multiple sclerosis
  • Compartmentalized inflammation and meningeal inflammation

Research interests include MRI markers, cerebrospinal fluid analysis, and immunological features linked to persistent central nervous system inflammation.

About Specializations

Azienda Ospedaliera Universitaria Integrata Verona runs clinical trials in conditions such as Cystic fibrosis, Progressive multiple sclerosis, Parkinson's disease, Staphylococcal infection, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

9 clinical trials

Parkinson's disease

Recruiting

Study of safinamide compared to placebo for pain relief in patients with Parkinson's disease who experience motor fluctuations

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Safinamide
  • Sponsor:Azienda Ospedaliera Universitaria Integrata Verona

Cystic fibrosis

Recruiting

Study on the Safety and Tolerability of Tamoxifen in Cystic Fibrosis Patients Not Eligible for CFTR Modulator Therapy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Tamoxifen
  • Sponsor:Azienda Ospedaliera Universitaria Integrata Verona

Progressive multiple sclerosis

Recruiting

Study on the Effects of Siponimod for Patients with Secondary Progressive Multiple Sclerosis

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Siponimod
  • Sponsor:Azienda Ospedaliera Universitaria Integrata Verona

Staphylococcal infection+1

Recruiting

Study on the Safety of Inhaled Teicoplanin for Treating Staphylococcus aureus Infections in Cystic Fibrosis Patients

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Teicoplanin
  • Sponsor:Azienda Ospedaliera Universitaria Integrata Verona

Progressive multiple sclerosis

Recruiting

Study on the Effects of Siponimod on Imaging and Immune Markers in Patients with Progressive Multiple Sclerosis

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Siponimod
  • Sponsor:Azienda Ospedaliera Universitaria Integrata Verona

Multiple sclerosis+2

Recruiting

Study on the Effects of Ozanimod on Inflammation in Patients with Relapsing Multiple Sclerosis

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ozanimod
  • Sponsor:Azienda Ospedaliera Universitaria Integrata Verona

Adenocarcinoma gastric

Recruiting

Study on Pressurized Intraperitoneal Aerosol Chemotherapy with Fluorouracil for Patients with Gastric Cancer with Peritoneal Metastases

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Levofolinate
  • Sponsor:Azienda Ospedaliera Universitaria Integrata Verona

Muscle spasticity

Recruiting

Study on the Safety and Effectiveness of IncobotulinumtoxinA for Treating Limb Spasticity in Children with Cerebral Palsy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
  • Sponsor:Azienda Ospedaliera Universitaria Integrata Verona

Osteoarthritis+1

Not yet recruiting

Effect of denosumab versus zoledronic acid on erosion progression in patients with erosive hand osteoarthritis and osteoporosis: a randomized controlled trial

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Denosumab
  • Sponsor:Azienda Ospedaliera Universitaria Integrata Verona

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.